To see the other types of publications on this topic, follow the link: BAFF.

Journal articles on the topic 'BAFF'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'BAFF.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lin, Wai, Joanne Hildebrand, and Gail Bishop. "New insights into TRAF-mediated regulation of BAFF receptor signals (P1110)." Journal of Immunology 190, no. 1_Supplement (2013): 64.2. http://dx.doi.org/10.4049/jimmunol.190.supp.64.2.

Full text
Abstract:
Abstract BAFF receptor (BAFFR), a member of the TNFR superfamily, binds to the pro-survival cytokine BAFF to promote B cell development and survival, and deficiencies of either BAFFR or BAFF result in inhibition of B cell development. BAFF-R engagement recruits TRAFs 2, 3 and 6 and activates the non-canonical NF-κB2 pathway. Current models propose that TRAF3 mediates degradation of the NF-κB activating kinase NIK, concluding that BAFFR-mediated TRAF3 degradation is necessary and sufficient for NF-κB2 activation. However, our recent studies of a mutant BAFFR indicate that this model is inadequa
APA, Harvard, Vancouver, ISO, and other styles
2

Krejsek, Jan, Martina Koláčková, Irena Lindrová, Radovan Slezák, and Ctirad Andrýs. "Increase of Intracellular BAFF in B Cells of Sjögren’s Patients Is Not Affected by Decrease of BAFFR." Acta Medica (Hradec Kralove, Czech Republic) 58, no. 1 (2015): 25–31. http://dx.doi.org/10.14712/18059694.2015.88.

Full text
Abstract:
The presence of a broad spectrum of autoantibodies in Sjögren’s syndrome (SjS) patients is the result of abnormal B-cell regulation that can be at least partially explained by abnormal BAFF/BAFFR regulation. The objective of this study was to determine both membrane and intracellular expression of BAFF/BAFFR in monocytes and B-cells in peripheral blood of 19 primary Sjögren’s syndrome patients and 20 healthy controls using flow cytometry. We also measured sBAFF in serum. Compared to healthy controls, both surface and intracellular expression of BAFF was significantly increased in monocytes and
APA, Harvard, Vancouver, ISO, and other styles
3

Gribbin, Caitlin, Dylan McNally, Ioannis Karagiannidis, et al. "Follicular Dendritic Cells Represent a Therapeutic Vulnerability in Early Follicular Lymphoma." Blood 144, Supplement 1 (2024): 739. https://doi.org/10.1182/blood-2024-198542.

Full text
Abstract:
Follicular lymphomas (FLs) arise from germinal center (GC) B cells and contain a rich tumor microenvironment (TME) including CD4+ and CD8+ T cells, macrophages, and lymphoid stromal cells, among which follicular dendritic cells (FDCs) are particularly abundant. FDCs interact with GC B cells through antigen presentation, secretion of BAFF, which binds to BAFFR to induce trophic signals, and secretion of CXCL13, which draws B cells into GCs via CXCR5. While the role of FDCs in FL is not fully understood, BAFFR expression has been associated with worse outcomes in diffuse large B-cell lymphoma. W
APA, Harvard, Vancouver, ISO, and other styles
4

Hildebrand, Joanne, and Gail Bishop. "TRAF6, a new member of the proximal signaling complex recruited by BAFFR and TACI in B lymphocytes (34.1)." Journal of Immunology 184, no. 1_Supplement (2010): 34.1. http://dx.doi.org/10.4049/jimmunol.184.supp.34.1.

Full text
Abstract:
Abstract The cytokines BAFF (B-cell activating factor of the TNF family, BLyS) and APRIL (a proliferation-inducing ligand) activate several major signaling cascades responsible for B-cell survival and homeostasis. Made primarily by myeloid cells, BAFF binds and activates three cell membrane receptors; BCMA (B-cell maturation antigen), TACI (transmembrane activator and CAML interactor), and BAFF-R (BAFF Receptor, BR3), while APRIL binds TACI and BCMA. Studies of genetically altered mice demonstrate that TACI and BCMA perform niche roles in B-cell Ig isotype switching and plasma cell maintenance
APA, Harvard, Vancouver, ISO, and other styles
5

Xu, Haiyan, Xizhou He, Renfang Xu, et al. "miR-338-5p indirectly regulate BAFF signal by targeting TRAF3 during renal allograft antibody-mediated rejection (P2200)." Journal of Immunology 190, no. 1_Supplement (2013): 69.38. http://dx.doi.org/10.4049/jimmunol.190.supp.69.38.

Full text
Abstract:
Abstract Objective: To investigate the regulation mechanism of B cell activating factor (BAFF) signal during antibody-mediated renal allograft rejection (ABMR), microRNAs chip assay and further studies were carried out. Methods: The renal allograft tissues were diagnosed according to Banff'2005 criteria. MicroRNA chip assay was done (tested group: 4 ABMR tissues with high expression of BAFF and C4d; controlled group: 4 IF-TA tissues with no expression of BAFF and C4d). 20 other renal allograft tissues were chosen for differentially expression microRNAs testification, and TRAF3, BAFF and BAFF-R
APA, Harvard, Vancouver, ISO, and other styles
6

Saidoune, F., N. Charles, J. Chezel, et al. "AB0140 BAFF NEUTRALIZATION HAS JANUS-FACED EFFECT ON ATHEROSCLEROSIS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 1370.3–1370. http://dx.doi.org/10.1136/annrheumdis-2020-eular.988.

Full text
Abstract:
Background:Cardiovascular diseases (CVD) are the leading cause of death in systemic lupus erythematosus (SLE). B cells play a key role in the pathogenesis of lupus and anti-BAFF therapy has been approved in SLE. Since mature B cells also promote atherosclerosis, BAFF neutralization is expected to have an atheroprotective effect in SLE.Objectives:The aim of our study was to test this hypothesis using a new mouse model with a mix susceptibility to lupus and atherosclerosis that received or not an anti-BAFF treatment, and in a cohort of SLE patients in whom we monitored carotid plaques, the B cel
APA, Harvard, Vancouver, ISO, and other styles
7

Alexaki, Vassilia-Ismini, Vassiliki Pelekanou, George Notas, et al. "B-Cell Maturation Antigen (BCMA) Activation Exerts Specific Proinflammatory Effects in Normal Human Keratinocytes and Is Preferentially Expressed in Inflammatory Skin Pathologies." Endocrinology 153, no. 2 (2012): 739–49. http://dx.doi.org/10.1210/en.2011-1504.

Full text
Abstract:
TNFα is known to be expressed in human skin, regulating immune-related responses. Here we report that human normal skin keratinocytes express the members of the TNF superfamily members A proliferation-inducing ligand (APRIL; TNFSF13), B cell-activating factor (BAFF; TNFSF13B), and their receptors, B cell maturation antigen (BCMA; TNFRSF17) and transmembrane activator, calcium-modulator, and cyclophilin ligand interactor (TACI; TNFRSF13B), in a distinct spatial pattern. Our data show a differential expression of these molecules within epidermal layers and skin appendages, whereas the BAFF-speci
APA, Harvard, Vancouver, ISO, and other styles
8

Hill, Thomas, Anthony Redmond, and Helen Dooley. "Investigating the functional roles of TNFSF13 family members in Cartilaginous Fishes." Journal of Immunology 210, no. 1_Supplement (2023): 224.03. http://dx.doi.org/10.4049/jimmunol.210.supp.224.03.

Full text
Abstract:
Abstract The TNFSF13 cytokines BAFF and APRIL along with their cognate receptors BAFFR, TACI, and BCMA play critical parts in the development, function, and maintenance of B cells in mammals. Despite the well-studied roles that BAFF and APRIL play in the immune systems of higher vertebrates, their evolutionary history and functions in non-mammalian organisms are not well understood. Recently, our lab has demonstrated that collectively the TNFSF is evolutionarily ancient, with most of its members having evolved over 450 million years ago in the jawed vertebrate ancestor. Interestingly, we found
APA, Harvard, Vancouver, ISO, and other styles
9

Xu, Haifeng C., Jun Huang, Vishal Khairnar, et al. "Deficiency of the B Cell-Activating Factor Receptor Results in Limited CD169+Macrophage Function during Viral Infection." Journal of Virology 89, no. 9 (2015): 4748–59. http://dx.doi.org/10.1128/jvi.02976-14.

Full text
Abstract:
ABSTRACTThe B cell-activating factor (BAFF) is critical for B cell development and humoral immunity in mice and humans. While the role of BAFF in B cells has been widely described, its role in innate immunity remains unknown. Using BAFF receptor (BAFFR)-deficient mice, we characterized BAFFR-related innate and adaptive immune functions following infection with vesicular stomatitis virus (VSV) and lymphocytic choriomeningitis virus (LCMV). We identified a critical role for BAFFR signaling in the generation and maintenance of the CD169+macrophage compartment. Consequently,Baffr−/−mice exhibited
APA, Harvard, Vancouver, ISO, and other styles
10

Prieto-Peña, D., S. Remuzgo Martinez, F. Genre, et al. "POS0113 BAFF-APRIL-BAFFR PATHWAY ON THE PATHOGENESIS OF IMMUNOGLOBULIN-A VASCULITIS." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 267.2–268. http://dx.doi.org/10.1136/annrheumdis-2021-eular.707.

Full text
Abstract:
Background:BAFF, APRIL and BAFFR are genes that encode cytokines with a key role in the development and survival of B-lymphocytes [1-4]: The B cell-activating factor (BAFF, also known as BLyS), a proliferation-inducing ligand (APRIL) and BAFF receptor (BAFF-R), respectively. Previous genetic studies have revealed that the BAFF-APRIL-BAFFR pathway is implicated in the genetic predisposition to several immune-mediated diseases [5].Objectives:To determine whether the BAFF-APRIL-BAFFR pathway represents a novel genetic risk factor for the pathogenesis of Immunoglobulin-A vasculitis (IgAV), an infl
APA, Harvard, Vancouver, ISO, and other styles
11

Prieto-Peña, D., F. Genre, S. Remuzgo Martinez, et al. "AB0146 BAFF, APRIL y BAFFR: DIFFERENTIAL BIOMARKERS BETWEEN IgA VASCULITIS AND IgA NEPHROPATHY?" Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 1203–4. http://dx.doi.org/10.1136/annrheumdis-2022-eular.425.

Full text
Abstract:
BackgroundIgA vasculitis (IgAV) and IgA nephropathy (IgAN) are inflammatory conditions [1, 2], that share pathogenic mechanisms [1], in which B-lymphocytes are described as key cells implicated in these processes. BAFF, APRIL and BAFF-R are cytokines implicated in the development of B-lymphocytes [3, 4] and in autoimmune processes [5, 6]. In this regard, an influence of BAFF, APRIL and BAFFR polymorphisms was observed on several immune-mediated conditions, being BAFF GCTGT>A a shared insertion-deletion variant for inflammatory conditions [7, 8].ObjectivesTo determine whether BAFF, APRIL and
APA, Harvard, Vancouver, ISO, and other styles
12

Lee, Sang-Ryul, Clifton Ramsdell, Suzanne McCray, Ramiro Diz та Stephen Clarke. "NF-κB inducing kinase as a key player in regulating autoreactive B cell maturation (P4048)". Journal of Immunology 190, № 1_Supplement (2013): 44.9. http://dx.doi.org/10.4049/jimmunol.190.supp.44.9.

Full text
Abstract:
Abstract The regulation of autoreactive B cells is crucial in immune systems to prevent developing autoimmune diseases in human and animal models. A critical peripheral B cell tolerance mechanism is exclusion of autoreactive B cells from the mature repertoire due to a failure to compete with non-autoreactive B cells. B cell activation factor (Baff) is one of the most important factors to discriminate autoreactive and non-autoreactive B cells in periphery. Therefore, the level of Baff expression in vivo is significant, since excess Baff can override exclusion and lead to autoimmunity, and may c
APA, Harvard, Vancouver, ISO, and other styles
13

Wang, Xiuli, Zhenyuan Dong, Wen-Chung Chang, et al. "CD19/BAFF-R Dual-Targeted CAR T Cells for the Treatment of Mixed Antigen-Negative Variants of Acute Lymphoblastic Leukemia." Blood 138, Supplement 1 (2021): 2783. http://dx.doi.org/10.1182/blood-2021-151293.

Full text
Abstract:
Abstract The results of clinical trials evaluating CD19-targeting chimeric antigen receptor (CAR) T cells are impressive, with overall response rates of up to 90% in B cell acute lymphoblastic leukemia (ALL) and 50-80% in lymphoma. Despite initial responses, antigen-negative relapse is common following treatment with CD19-targeted therapies and is estimated to occur in up to 39% of patients. One approach of addressing this problem is to utilize dual-targeting CAR T cells, a strategy that has recently been applied to CD19/CD22 for ALL, CS1/BCMA, and BCMA/GPRC5D for multiple myeloma. Dual-target
APA, Harvard, Vancouver, ISO, and other styles
14

Bossen, Claudia, Teresa G. Cachero, Aubry Tardivel, et al. "TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts." Blood 111, no. 3 (2008): 1004–12. http://dx.doi.org/10.1182/blood-2007-09-110874.

Full text
Abstract:
Abstract The cytokine BAFF binds to the receptors TACI, BCMA, and BAFF-R on B cells, whereas APRIL binds to TACI and BCMA only. The signaling properties of soluble trimeric BAFF (BAFF 3-mer) were compared with those of higher-order BAFF oligomers. All forms of BAFF bound BAFF-R and TACI, and elicited BAFF-R–dependent signals in primary B cells. In contrast, signaling through TACI in mature B cells or plasmablasts was only achieved by higher-order BAFF and APRIL oligomers, all of which were also po-tent activators of a multimerization-dependent reporter signaling pathway. These results indicate
APA, Harvard, Vancouver, ISO, and other styles
15

Secreto, Frank J., Michelle K. Manske, Tammy Price-Troska, et al. "A Lymphoma-Associated Mutation in BAFF-R Drives Constitutive PI3K Signaling and Increased Expression of Pro-Survival Genes." Blood 118, no. 21 (2011): 2642. http://dx.doi.org/10.1182/blood.v118.21.2642.2642.

Full text
Abstract:
Abstract Abstract 2642 BAFF is essential for B cell maturation, and a lack of either BAFF or its primary receptor, BAFF-R, results in a severe depletion of T2 marginal zone and follicular B cells. Elevated serum BAFF levels have been correlated with an increased risk of developing non-Hodgkin's lymphoma (NHL), along with a more aggressive phenotype. A growing body of genetic evidence points toward an association between the development of human disease and variation in genes encoding BAFF and its receptors. Recently, we characterized a novel lymphoma-associated mutation in TNFRSF13C, the gene
APA, Harvard, Vancouver, ISO, and other styles
16

Beaudette-Zlatanova, Britte, Venkata Yeramilli, and Katherine Knight. "A role for BAFF during myelopoiesis (153.25)." Journal of Immunology 186, no. 1_Supplement (2011): 153.25. http://dx.doi.org/10.4049/jimmunol.186.supp.153.25.

Full text
Abstract:
Abstract B cell activating factor (BAFF) is expressed in several tissues including the bone marrow (BM). Although BAFF is important for B cell homeostasis and survival, its effects on other leukocytes has not been elucidated. While studying the role of BAFF in rabbit, we discovered that BAFF binds peripheral blood myeloid cells and MHC Class IIneg CD14neg myeloperoxidase (MPO)pos myeloid progenitors (MP) in the BM. Addition of BAFF to co-cultures of unfractionated rabbit BM cells with the murine BM stroma cell line, OP9 stimulated proliferation of rabbit cells resulting in an increase in the t
APA, Harvard, Vancouver, ISO, and other styles
17

Hildebrand, Joanne M., Zhenghua Luo, Michelle Manske, et al. "A BAFF-R Mutation Associated with Non-Hodgkin Lymphoma Exhibits Altered TRAF Binding and Reveals New Insights Into Proximal BAFF-R Signaling." Blood 116, no. 21 (2010): 468. http://dx.doi.org/10.1182/blood.v116.21.468.468.

Full text
Abstract:
Abstract Abstract 468 The requirement for BAFF and BAFF-R in normal human and murine B cells is well studied, but there is also significant evidence to suggest that BAFF plays an important role in malignant B cell proliferation and survival. Serum BAFF levels are elevated in patients with non-Hodgkin lymphoma (NHL) and high BAFF levels correlate with aggressive disease and a poor response to therapy. There is also increasing genetic evidence suggesting an association between the development of human disease and genetic variation in genes encoding BAFF and its receptors. Mutations in TNFRSF13B
APA, Harvard, Vancouver, ISO, and other styles
18

Hildebrand, Joanne M., Zhenghua Luo, Michelle K. Manske, et al. "A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling." Journal of Experimental Medicine 207, no. 12 (2010): 2569–79. http://dx.doi.org/10.1084/jem.20100857.

Full text
Abstract:
The cytokine B cell activating factor (BAFF) and its receptor, BAFF receptor (BAFF-R), modulate signaling cascades critical for B cell development and survival. We identified a novel mutation in TNFRSF13C, the gene encoding human BAFF-R, that is present in both tumor and germline tissue from a subset of patients with non-Hodgkin lymphoma. This mutation encodes a His159Tyr substitution in the cytoplasmic tail of BAFF-R adjacent to the TRAF3 binding motif. Signaling through this mutant BAFF-R results in increased NF-κB1 and NF-κB2 activity and increased immunoglobulin production compared with th
APA, Harvard, Vancouver, ISO, and other styles
19

Feng, Guo-dong, Xiao-chang Xue, Mei-li Gao, et al. "Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis." BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/854954.

Full text
Abstract:
B cell activating factor (BAFF) is a cytokine of tumor necrosis factor family mainly produced by monocytes and dendritic cells. BAFF can regulate the proliferation, differentiation, and survival of B lymphocytes by binding with BAFF-R on B cell membrane. Accumulating evidences showed that BAFF played crucial roles and was overexpressed in various autoimmune diseases such as systemic lupus erythematous (SLE) and rheumatoid arthritis (RA). This suggests that BAFF may be a therapeutic target for these diseases. In the present study, we developed a BAFF therapeutic vaccine by coupling a T helper c
APA, Harvard, Vancouver, ISO, and other styles
20

Tai, Yu-Tzu, Xian-Feng Li, Rory Coffey, et al. "Role of BAFF in Adhesion and Growth of Human Multiple Myeloma Cells in the Bone Marrow Microenvironment." Blood 106, no. 11 (2005): 627. http://dx.doi.org/10.1182/blood.v106.11.627.627.

Full text
Abstract:
Abstract Recent studies have underscored the role of B-cell activating factor (BAFF), a member of the tumor necrosis factor superfamily, in promoting the survival of malignant B cells, including human MM. Since the tumor bone marrow microenvironment plays a crucial role in MM cell growth and survival, we here characterize the functional significance of BAFF in the interaction between MM and bone marrow stromal cells (BMSCs), and further defined molecular mechanisms regulating these processes. We first confirmed the expression of BAFF and its receptors (BCMA, TACI, BAFF-R) on majority of MM cel
APA, Harvard, Vancouver, ISO, and other styles
21

Möckel, Tamara, Sebastian Boegel, and Andreas Schwarting. "Transcriptome Analysis of BAFF/BAFF-R System in Murine Nephrotoxic Serum Nephritis." International Journal of Molecular Sciences 25, no. 10 (2024): 5415. http://dx.doi.org/10.3390/ijms25105415.

Full text
Abstract:
Chronic kidney disease (CKD) is an emerging cause for morbidity and mortality worldwide. Acute kidney injury (AKI) can transition to CKD and finally to end-stage renal disease (ESRD). Targeted treatment is still unavailable. NF-κB signaling is associated with CKD and activated by B cell activating factor (BAFF) via BAFF-R binding. In turn, renal tubular epithelial cells (TECs) are critical for the progression of fibrosis and producing BAFF. Therefore, the direct involvement of the BAFF/BAFF-R system to the pathogenesis of CKD is conceivable. We performed non-accelerated nephrotoxic serum nephr
APA, Harvard, Vancouver, ISO, and other styles
22

Sarantopoulos, Stefanie, Kristen E. Stevenson, Haesook T. Kim, et al. "BAFF/Blys Levels Correlate with Disease Activity and Alter Peripheral B Cell Subsets in Patients with Chronic GVHD." Blood 108, no. 11 (2006): 41. http://dx.doi.org/10.1182/blood.v108.11.41.41.

Full text
Abstract:
Abstract Patients with chronic graft versus host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) have been found to have high titers of allo-reactive antibodies, but a role for B cells in the pathology of this disease remains undefined. B Cell Activating Factor, BAFF/Blys (BAFF), promotes differentiation and expansion of antigen-activated B cells and contributes to loss of B cell tolerance in animal models. We hypothesized that the BAFF/BAFF receptor (BAFF-R) pathway may perpetuate potentially allo- or auto-reactive antigen-experienced CD27+ B cells in patients
APA, Harvard, Vancouver, ISO, and other styles
23

Jia, Wei, Jonathan C. Poe, Hsuan Su, et al. "BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation." Blood 137, no. 18 (2021): 2544–57. http://dx.doi.org/10.1182/blood.2020008040.

Full text
Abstract:
Abstract Patients with chronic graft-versus-host disease (cGVHD) have increased B cell–activating factor (BAFF) levels, but whether BAFF promotes disease after allogeneic bone marrow transplantation (allo-BMT) remains unknown. In a major histocompatibility complex–mismatched model with cGVHD-like manifestations, we first examined B-lymphopenic μMT allo-BMT recipients and found that increased BAFF levels in cGVHD mice were not merely a reflection of B-cell number. Mice that later developed cGVHD had significantly increased numbers of recipient fibroblastic reticular cells with higher BAFF trans
APA, Harvard, Vancouver, ISO, and other styles
24

Tschumper, Renee C., Jaime R. Darce, Xiaosheng Wu, Stephen A. Mihalcik, and Diane F. Jelinek. "Comprehensive Analysis of BAFF Binding Receptor Profiles and Receptor Occupancy in B Cell Chronic Lymphocytic Leukemia: Identification of Discrete Phenotypic Subgroups." Blood 110, no. 11 (2007): 1135. http://dx.doi.org/10.1182/blood.v110.11.1135.1135.

Full text
Abstract:
Abstract B cell-activating factor (BAFF) is known to regulate normal B cell development and homeostasis primarily by signaling through the high affinity receptor, BAFF-R, one of three BAFF binding receptors (BBRs). BAFF also binds two other receptors, BCMA and TACI with lesser affinity. We have recently shown that normal peripheral blood (PB) B cells express high levels of prebound soluble BAFF, which is lost upon B cell activation. Because of BAFF’s activity on normal B cells, we have been interested in the roles of BAFF and BBRs in B cell chronic lymphocytic leukemia (B-CLL). We and others h
APA, Harvard, Vancouver, ISO, and other styles
25

Sun, Jian, Xiaojuan Zhang, Zhao Zhen, and Xiafei Hao. "BAFF antagonists designed by computer-aided drug design inhibited the interaction of BAFF with its receptors." Journal of Immunology 200, no. 1_Supplement (2018): 164.17. http://dx.doi.org/10.4049/jimmunol.200.supp.164.17.

Full text
Abstract:
Abstract BAFF is a critical factor for B cell maturation and survival, and its overexpression is involved in pathogenesis of autoimmune diseases. As blockade of BAFF activity significantly improves the symptoms of autoimmune diseases such as SLE and RA, BAFF is a promising therapeutic target for treating these diseases. Currently, most BAFF antagonists are antibodies against BAFF or soluble BAFF receptor-IgG1 Fc fusion proteins. Small molecules such as peptides as antagonists to block the biological activity of cytokines have been investigated intensively. Based on the crystal structures of th
APA, Harvard, Vancouver, ISO, and other styles
26

Kim, Kwang Soo, Ilo Jou, and Sang Myun Park. "Functional Implication of BAFF Synthesis and Release in Gmix-stimulated Microglia (B174)." Journal of Immunology 178, no. 1_Supplement (2007): LB36. http://dx.doi.org/10.4049/jimmunol.178.supp.b174.

Full text
Abstract:
Abstract BAFF (B-cell activating factor) is a recently identified member of TNF ligand superfamily that plays a critical role in B cell differentiation, survival, and regulation of immunoglobulin production. It exerts its effect by binding to three receptors: BAFF-R (BAFF receptor), TACI (transmembrane activator and CAML interactor), and BCMA (B-cell maturation antigen) which was known to be primarily expressed in B-lineage cells. In this present study, we examined whether or not BAFF is also expressed in microglia and the synthesis and release of BAFF is regulated by stimuli. BAFF is expresse
APA, Harvard, Vancouver, ISO, and other styles
27

Zhu, Pengpeng, Guoteng Ou, Ting Zhou, et al. "The Polysaccharide from Dendrobium officinale Can Improve Mice with Sjögren’s Syndrome by Regulating BAFF and Fas Expressions." Journal of Food Biochemistry 2023 (December 28, 2023): 1–14. http://dx.doi.org/10.1155/2023/4733651.

Full text
Abstract:
Exploring herbs and their compounds for potential drugs is a significant research focus due to the incurable nature of Sjögren’s syndrome (SS), a prevalent chronic inflammatory autoimmune disease. Dendrobium officinale polysaccharide (DOP) has demonstrated diverse biological effects, particularly in immunomodulation. Nonetheless, limited research has been conducted on DOP concerning the treatment of SS. This research aims to examine the impacts of DOP on experimental SS (ESS) mice and its possible mechanisms. An ESS animal model was established using the immune induction method. Besides the co
APA, Harvard, Vancouver, ISO, and other styles
28

Maia, Sara, Sambasiva P. Rao, Stephen E. Sallan, Lee M. Nadler, and Angelo A. Cardoso. "Aberrant Expression of BAFF System Molecules on B-Cell Precursor Leukemia Modulates Tumor Cell Survival: Novel Targets for Therapeutic Intervention." Blood 104, no. 11 (2004): 989. http://dx.doi.org/10.1182/blood.v104.11.989.989.

Full text
Abstract:
Abstract Identification of pathways that support the survival and proliferation of acute lymphoblastic leukemia (ALL) cells will provide novel targets for therapeutic intervention. BAFF and APRIL, with their receptors, BAFF-R, BCMA and TACI are members of the TNF family that play a critical role in the survival of mature B cells but not of normal B cell precursors. We sought to determine whether BAFF/APRIL and their receptors might be aberrantly expressed on B-cell precursor ALL. Surprisingly, tumor cells from 28 of 29 ALL patients expressed mRNA for at least one of these receptors. Using flow
APA, Harvard, Vancouver, ISO, and other styles
29

Awe, Olufolakemi, Rukhsana Jabeen, and Mark Kaplan. "Th9 cells secrete BAFF (P1447)." Journal of Immunology 190, no. 1_Supplement (2013): 174.6. http://dx.doi.org/10.4049/jimmunol.190.supp.174.6.

Full text
Abstract:
Abstract The B-cell activating factor (BAFF) is essential for proper B-cell development. Cells of the innate immune system including macrophages and dendritic cells are the primary source of BAFF. The BAFF protein has two forms, soluble and membrane bound. The membrane bound form of BAFF can become soluble following furin convertase-mediated digestion.. Through microarray analysis comparing the gene profile of Th9, Th2 and T-regulatory cells we found that expression of the gene encoding BAFF (Tnfsf13b) was enriched within the Th9 subset. Using qPCR, intracellular staining, and ELISA, we have c
APA, Harvard, Vancouver, ISO, and other styles
30

Ragheb, Samia, Yanfeng Li, Paula Dore-Duffy, and Robert Lisak. "Cytokine regulation of BAFF expression in human myeloid cells (P3005)." Journal of Immunology 190, no. 1_Supplement (2013): 114.3. http://dx.doi.org/10.4049/jimmunol.190.supp.114.3.

Full text
Abstract:
Abstract B-cell activating factor (BAFF) has an essential role in B cell homeostasis. It is synthesized and released by myeloid cells (monocytes & macrophages). BAFF over-expression promotes the survival and maturation of autoreactive B cells. Increased BAFF levels are found in several human autoimmune diseases, suggesting a role for BAFF in disease pathogenesis and progression. However, the regulatory signals that affect BAFF production are largely unknown. Using the human monocytic cell line THP-1, we examined the capacity of several cytokines to modulate BAFF expression; these included
APA, Harvard, Vancouver, ISO, and other styles
31

Ragheb, Samia, and Robert P. Lisak. "B-Cell-Activating Factor and Autoimmune Myasthenia Gravis." Autoimmune Diseases 2011 (2011): 1–10. http://dx.doi.org/10.4061/2011/939520.

Full text
Abstract:
BAFF is a potent B-cell survival factor, and it plays an essential role in B-cell homeostasis and B-cell function in the periphery. Both normal and autoreactive B cells are BAFF dependent; however, excess BAFF promotes the survival, growth, and maturation of autoreactive B cells. When overexpressed, BAFF protects B cells from apoptosis, thereby contributing to autoimmunity. Three independent studies have shown higher BAFF levels in the circulation of MG patients. BAFF may play an important role in the pathogenesis of MG. BAFF antagonists may well provide new treatment options for MG patients,
APA, Harvard, Vancouver, ISO, and other styles
32

Patke, Alina, Ingrid Mecklenbräuker, Hediye Erdjument-Bromage, Paul Tempst та Alexander Tarakhovsky. "BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanism". Journal of Experimental Medicine 203, № 11 (2006): 2551–62. http://dx.doi.org/10.1084/jem.20060990.

Full text
Abstract:
B cell life depends critically on the cytokine B cell–activating factor of the tumor necrosis factor family (BAFF). Lack of BAFF signaling leads to B cell death and immunodeficiency. Excessive BAFF signaling promotes lupus-like autoimmunity. Despite the great importance of BAFF to B cell biology, its signaling mechanism is not well characterized. We show that BAFF initiates signaling and transcriptional programs, which support B cell survival, metabolic fitness, and readiness for antigen-induced proliferation. We further identify a BAFF-specific protein kinase C β–Akt signaling axis, which pro
APA, Harvard, Vancouver, ISO, and other styles
33

Mulazzani, Matthias, Xíaolan Zhou, Wenlong Zhang, Andreas Straube, and Louisa von Baumgarten. "TMOD-33. THE ROLE OF BAFF-R SIGNALING IN THE GROWTH OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA." Neuro-Oncology 22, Supplement_2 (2020): ii235. http://dx.doi.org/10.1093/neuonc/noaa215.983.

Full text
Abstract:
Abstract Primary CNS lymphoma (PCNSL) is an aggressive brain tumor. Despite improvements in therapeutic algorithms, long-term survival remains rare, illustrating an urgent need for novel therapeutic targets. BAFF-R is a pro-survival receptor expressed on most malignant B cells, including PCNSL. To date, its role in PCNSL growth remains elusive. Here, we created a BAFF-R knockout lymphoma cell line (BAFF-R-KO) using CRISPR-Cas9. In serum-starved conditions, BAFF-R-KO cells exhibit decreased viability in vitro compared to BAFF-R+ cells. Combining an orthotopic mouse model of PCNSL with chronic c
APA, Harvard, Vancouver, ISO, and other styles
34

Krumbholz, Markus, Diethilde Theil, Tobias Derfuss, et al. "BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma." Journal of Experimental Medicine 201, no. 2 (2005): 195–200. http://dx.doi.org/10.1084/jem.20041674.

Full text
Abstract:
We report that B cell–activating factor of the tumor necrosis factor (TNF) family (BAFF) is expressed in the normal human brain at ∼10% of that in lymphatic tissues (tonsils and adenoids) and is produced by astrocytes. BAFF was regularly detected by enzyme-linked immunosorbent assay in brain tissue lysates and in normal spinal fluid, and in astrocytes by double fluorescence microscopy. Cultured human astrocytes secreted functionally active BAFF after stimulation with interferon-γ and TNF-α via a furin-like protease-dependent pathway. BAFF secretion per cell was manifold higher in activated ast
APA, Harvard, Vancouver, ISO, and other styles
35

Kern, Catherine, Jean-François Cornuel, Christian Billard, et al. "Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway." Blood 103, no. 2 (2004): 679–88. http://dx.doi.org/10.1182/blood-2003-02-0540.

Full text
Abstract:
Abstract Tumor necrosis factor (TNF) superfamily members BAFF, or B-cell activation factor of the TNF family, and APRIL, a proliferation-inducing ligand, are involved in normal B-cell survival and differentiation. They interact with 3 receptors: BAFF-R, specific to BAFF; and TACI and BCMA, which are shared by BAFF and APRIL. We tested the potential role of these proteins in B-cell chronic lymphocytic leukemia (B-CLL) resistance to apoptosis. TACI and BAFF-R mRNAs were found in leukemic B cells. BAFF and APRIL mRNAs and proteins were detected in B-CLL leukemic cells and normal blood or tonsil-d
APA, Harvard, Vancouver, ISO, and other styles
36

Tada, S., T. Yasui, T. Okuno, et al. "BAFF controls neural cell survival through BAFF receptor." Journal of the Neurological Sciences 333 (October 2013): e689. http://dx.doi.org/10.1016/j.jns.2013.07.2380.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Tada, Satoru, Teruhito Yasui, Yuji Nakatsuji, et al. "BAFF Controls Neural Cell Survival through BAFF Receptor." PLoS ONE 8, no. 7 (2013): e70924. http://dx.doi.org/10.1371/journal.pone.0070924.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Hu, Shanshan, Rui Wang, Mei Zhang, et al. "BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway." Biomedicine & Pharmacotherapy 114 (June 2019): 108796. http://dx.doi.org/10.1016/j.biopha.2019.108796.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Stohl, William, Ning Yu, and Ying Wu. "B Cell and T Cell Dissimilarities in BAFF-Deficient versus BR3-Deficient C57BL/6 Mice." Journal of Immunology 209, no. 11 (2022): 2133–40. http://dx.doi.org/10.4049/jimmunol.2200620.

Full text
Abstract:
Abstract BAFF is a potent B cell survival and differentiation factor with three receptors, TACI, BCMA, and BR3. B cells are greatly reduced in BAFF-deficient mice, and among mice deficient in a single BAFF receptor, B cell reduction is characteristic only of BR3-deficient mice. Nevertheless, there may be important differences between BR3-deficient mice, in which interactions between BAFF and only BR3 are abrogated, and BAFF-deficient mice, in which interactions between BAFF and all its receptors are abrogated. We demonstrate that: 1) the numbers of CD19+ cells in C57BL/6 (B6).Baff−/− and B6.Br
APA, Harvard, Vancouver, ISO, and other styles
40

Ferrer, Gerardo, Kate E. Hodgson, Pau Abrisqueta, et al. "BAFF and APRIL in Chronic Lymphocytic Leukemia: Clinico-Biological Correlates and Prognostic Significance." Blood 114, no. 22 (2009): 1235. http://dx.doi.org/10.1182/blood.v114.22.1235.1235.

Full text
Abstract:
Abstract Abstract 1235 Poster Board I-257 BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) are TNF family proteins that upregulate anti-apoptotic genes through the NF-kB pathway. Studies in vitro suggest that BAFF and APRIL protect neoplastic B cells from apoptosis in chronic lymphoproliferative disorders (CLPD) including chronic lymphocytic leukemia (CLL). Serum BAFF levels have been previously shown to be lower in CLL than in other CLPD or normal subjects. To contribute to a better understanding of their role in CLL, we analyzed BAFF and APRIL at mRNA and protein s
APA, Harvard, Vancouver, ISO, and other styles
41

Chen, Jing, Donghua He, Xing Guo, et al. "Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma." Blood 128, no. 22 (2016): 4429. http://dx.doi.org/10.1182/blood.v128.22.4429.4429.

Full text
Abstract:
Abstract Background:B-cell-activating factor (BAFF) is a member of the TNF family that critical for maintenance of B-cell development and homeostasis. BAFF receptor (BAFF-R), B-cell maturation antigen (BCMA) and transmembrane activator and CAML interactor (TACI) are three BAFF receptors. It has been reported that BAFF is expressed by neutrophils, monocytes, dentritic cells and macrophages and modulates the proliferation, survival and drug resistance of multiple myeloma (MM) cells. Our previous study showed that, macrophages protect MM cells from drug-induced apoptosis by direct interaction wit
APA, Harvard, Vancouver, ISO, and other styles
42

Chou, Ho, Lai, et al. "B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration." International Journal of Molecular Sciences 20, no. 20 (2019): 5022. http://dx.doi.org/10.3390/ijms20205022.

Full text
Abstract:
B-cell activating factor (BAFF) is found to be associated with the histological severity of nonalcoholic steatohepatitis (NASH). BAFF was also found to have a protective role in hepatic steatosis via down regulating the expression of steatogenesis genes and enhancing steatosis in hepatocytes through BAFF-R. However, the roles of BAFF during liver regeneration are not well defined. In this study, C57/B6 mice with 70% partial hepatectomy were used as a liver regeneration model. BAFF expression was determined by enzyme immunoassay, and anti-BAFF-neutralizing antibodies were administered to confir
APA, Harvard, Vancouver, ISO, and other styles
43

Rezazadeh, Maryam, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, et al. "Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity." Archives of Rheumatology 38, no. 3 (2023): 429–40. http://dx.doi.org/10.46497/archrheumatol.2023.9549.

Full text
Abstract:
Objectives: This study investigated the correlation between serum and urinary B cell-activating factor (BAFF) levels and systemic lupus erythematosus (SLE) disease activity. Patients and methods: This case-control study was conducted with 87 participants between December 2020 and September 2021. Sixty-two SLE patients who fulfilled the eligibility criteria were enrolled. SLE patients were categorized into active (n=34) and inactive (n=28) groups based on their Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) scores. The control group consisted of 25 healthy subjects. Serum
APA, Harvard, Vancouver, ISO, and other styles
44

Le Pottier, Laëtitia, Boutahar Bendaoud, Yves Renaudineau, Pierre Youinou, Jacques-Olivier Pers, and Capucine Daridon. "New ELISA for B Cell–Activating Factor." Clinical Chemistry 55, no. 10 (2009): 1843–51. http://dx.doi.org/10.1373/clinchem.2009.129940.

Full text
Abstract:
Abstract Background: The B cell–activating factor of the TNF family (BAFF) is upregulated in autoimmune diseases, but a number of conflicting results have cast doubts on the reliability of the ELISA protocols currently used for its quantification. This situation led us to develop a new ELISA for the measurement of BAFF. Methods: BAFF was purified for use alongside nonglycosylated recombinant BAFF. Two monoclonal antibodies (mAbs) and two polyclonal antibodies (pAbs) to BAFF were used. Results: The optimization process showed that the pAb format was preferable to the mAb format as capture antib
APA, Harvard, Vancouver, ISO, and other styles
45

Rihacek, Michal, Julie Bienertova-Vasku, Dalibor Valik, Jaroslav Sterba, Katerina Pilatova, and Lenka Zdrazilova-Dubska. "B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia." BioMed Research International 2015 (2015): 1–9. http://dx.doi.org/10.1155/2015/792187.

Full text
Abstract:
B-cell activating factor (BAFF) is a cytokine and adipokine of the TNF ligand superfamily. The main biological function of BAFF in maintaining the maturation of B-cells to plasma cells has recently made it a target of the first FDA-approved selective BAFF antibody, belimumab, for the therapy of systemic lupus erythematosus. Concomitantly, the role of BAFF in cancer has been a subject of research since its discovery. Here we review BAFF as a biomarker of malignant disease activity and prognostic factor in B-cell derived malignancies such as multiple myeloma. Moreover, anti-BAFF therapy seems to
APA, Harvard, Vancouver, ISO, and other styles
46

Birnbaum, Tobias, Sigrid Langer, Sigrun Roeber, Louisa Von Baumgarten, and Andreas Straube. "Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma." Neurology International 5, no. 1 (2013): 4. http://dx.doi.org/10.4081/ni.2013.e4.

Full text
Abstract:
B-cell activating factor belonging to the tumor necrosis factor family (BAFF) and a proliferating inducing ligand (APRIL) might play an important role in the pathogenesis of systemic B-cell malignancies. However, the BAFF/APRIL system has not been systematically evaluated in primary central nervous system lymphoma (PCNSL) to date. We assessed the expression of BAFF, APRIL and its receptors BAFF-R (BAFF receptor), BCMA (B-cell maturation antigen) and TACI (transmembrane activator and calcium modulator cyclophilin ligand interactor) in five PCNSL specimens by immunohistochemical staining. We fou
APA, Harvard, Vancouver, ISO, and other styles
47

Castigli, Emanuela, Stephen A. Wilson, Sumi Scott, et al. "TACI and BAFF-R mediate isotype switching in B cells." Journal of Experimental Medicine 201, no. 1 (2005): 35–39. http://dx.doi.org/10.1084/jem.20032000.

Full text
Abstract:
The tumor necrosis factor family members BAFF and APRIL induce Ig isotype switching in human B cells. We analyzed the ability of BAFF and APRIL to induce isotype switching in murine B cells to IgG1, IgA, and IgE. APRIL and BAFF each engage two receptors, transmembrane activator and calcium-modulator and cytophilin ligand interactor (TACI) and B cell maturation antigen (BCMA), on B cells. In addition, BAFF engages a third receptor on B cells, BAFF-R. To determine the role of these receptors in isotype switching, we examined B cells from mice deficient in TACI, BCMA, and BAFF-R. The results obta
APA, Harvard, Vancouver, ISO, and other styles
48

Chiu, April, Xugang Qiao, Bing He, et al. "The TNF Family Members BAFF and APRIL Play an Important Role in Hodgkin Lymphoma." Blood 106, no. 11 (2005): 22. http://dx.doi.org/10.1182/blood.v106.11.22.22.

Full text
Abstract:
Abstract Introduction. B cell-activating factor of the TNF family (BAFF) and a proliferation-inducing ligand (APRIL), a BAFF-related molecule, play a key role in the survival and proliferation of mature B cells. In addition, BAFF and APRIL cooperate with IL-4 to induce class switch DNA recombination (CSR) from IgM (or IgG) to IgG, IgA or IgE. This process requires activation-induced-cytidine deaminase (AID), a DNA-editing enzyme involved also in Ig somatic hypermutation and lymphomagenesis. BAFF and APRIL are usually produced by myeloid cells, including dendritic cells, macrophages and granulo
APA, Harvard, Vancouver, ISO, and other styles
49

Kuley, Runa, Kevin E. Draves, Deborah H. Fuller, Natalia V. Giltiay, Edward A. Clark, and Daniela Giordano. "B cell activating factor (BAFF) from neutrophils and dendritic cells is required for protective B cell responses against Salmonella typhimurium infection." PLOS ONE 16, no. 10 (2021): e0259158. http://dx.doi.org/10.1371/journal.pone.0259158.

Full text
Abstract:
Mice lacking B cells are more susceptible to S. typhimurium infection. How B cells contribute to protective immunity against Salmonella and what signals drive their activation are still unclear. Neutrophils (Nphs), monocytes (MOs), and dendritic cells (DCs) are involved in early immune responses to control the initial replication of S. typhimurium. These cells can produce B cell activating factor (BAFF) required for mature B cell survival and may help regulate B cell responses during Salmonella infection. Using BAFF reporter mice (BAFF-RFP+/-), we discovered that an i.p. infection with a virul
APA, Harvard, Vancouver, ISO, and other styles
50

Hakim, Frances T., Najibah Rehman, John Dickinson, et al. "Elevated BAFF Is Correlated with Inflammatory Processes in Chronic Graft Versus Host Disease and Supports Increases in Transitional B Cells." Blood 112, no. 11 (2008): 465. http://dx.doi.org/10.1182/blood.v112.11.465.465.

Full text
Abstract:
Abstract B Cell Activating Factor of the TNF Family (BAFF) plays a critical role in the survival, activation and function of B cells. Elevated levels of BAFF in plasma, however, have been reported in systemic autoimmune disorders and in chronic graft versus host disease (CGVHD). We similarly observed elevated plasma BAFF levels in 98 patients in an ongoing NCI CGVHD natural history protocol, with a median of 2653 pg/ml (range 92 to 14907), as compared to 556 pg/ml (range 75 to 1834) in 18 normal donors. Furthermore, in a subset of 40 patients in which severity of cutaneous CGVHD could be asses
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!